Unknown

Dataset Information

0

A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.


ABSTRACT: Topiramate, an anticonvulsant medication, is an efficacious treatment for alcohol dependence. To date, little is known about genetic moderators of side effects from topiramate. The objective of this study was to examine 3 single nucleotide polymorphisms (SNPs) of the glutamate receptor GluR5 gene (GRIK1) as predictors of topiramate-induced side effects in the context of a laboratory study of topiramate. Heavy drinkers (n=51, 19 women and 32 men), 75% of whom met criteria for an alcohol use disorder, completed a 5-week dose escalation schedule to a target dose of either 200 or 300 mg or matched placebo. The combined medication groups were compared with placebo-treated individuals for side effects at target dose. Analyses revealed that an SNP in intron 9 of the GRIK1 gene (rs2832407) was associated with the severity of topiramate-induced side effects and with serum levels of topiramate. Genes underlying glutamatergic neurotransmission, such as the GRIK1 gene, may help predict heterogeneity in topiramate-induced side effects. Future studies in larger samples are needed to more fully establish these preliminary findings.

SUBMITTER: Ray LA 

PROVIDER: S-EPMC3682424 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.

Ray Lara A LA   Miranda Robert R   MacKillop James J   McGeary John J   Tidey Jennifer W JW   Rohsenow Damaris J DJ   Gwaltney Chad C   Swift Robert W RW   Monti Peter M PM  

Experimental and clinical psychopharmacology 20090401 2


Topiramate, an anticonvulsant medication, is an efficacious treatment for alcohol dependence. To date, little is known about genetic moderators of side effects from topiramate. The objective of this study was to examine 3 single nucleotide polymorphisms (SNPs) of the glutamate receptor GluR5 gene (GRIK1) as predictors of topiramate-induced side effects in the context of a laboratory study of topiramate. Heavy drinkers (n=51, 19 women and 32 men), 75% of whom met criteria for an alcohol use disor  ...[more]

Similar Datasets

| S-EPMC3997125 | biostudies-literature
| S-EPMC4176606 | biostudies-literature
| S-EPMC4845738 | biostudies-literature
| S-EPMC7571929 | biostudies-literature
| S-EPMC5297738 | biostudies-literature
| S-EPMC10604848 | biostudies-literature
| S-EPMC7613765 | biostudies-literature
| S-EPMC4293099 | biostudies-literature
| S-EPMC26554 | biostudies-literature
| S-EPMC8209023 | biostudies-literature